USD 2.21
(-4.33%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 22.92 Million USD | -11.86% |
2022 | 26.01 Million USD | -6.34% |
2021 | 27.77 Million USD | 227.18% |
2020 | 8.48 Million USD | -45.75% |
2019 | 15.64 Million USD | -32.13% |
2018 | 23.05 Million USD | 25.09% |
2017 | 18.42 Million USD | -12.03% |
2016 | 20.94 Million USD | -19.88% |
2015 | 26.14 Million USD | -13.24% |
2014 | 30.13 Million USD | -1.14% |
2013 | 30.48 Million USD | -10.44% |
2012 | 34.04 Million USD | 98.58% |
2011 | 17.14 Million USD | 81.96% |
2010 | 9.42 Million USD | 7.14% |
2009 | 8.79 Million USD | -8.74% |
2008 | 9.63 Million USD | 21.87% |
2007 | 7.9 Million USD | 18.77% |
2006 | 6.65 Million USD | -17.63% |
2005 | 8.08 Million USD | 28.67% |
2004 | 6.28 Million USD | -38.49% |
2003 | 10.21 Million USD | -10.19% |
2002 | 11.37 Million USD | 7.24% |
2001 | 10.6 Million USD | -9.4% |
2000 | 11.7 Million USD | -3.28% |
1999 | 12.1 Million USD | 3.42% |
1998 | 11.7 Million USD | 116.67% |
1997 | 5.4 Million USD | 58.82% |
1996 | 3.4 Million USD | 25.93% |
1995 | 2.7 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 24.42 Million USD | 6.53% |
2024 Q2 | 23.12 Million USD | -5.3% |
2023 Q1 | 23.42 Million USD | -9.94% |
2023 Q3 | 21.35 Million USD | -3.86% |
2023 Q2 | 22.21 Million USD | -5.18% |
2023 Q4 | 22.92 Million USD | 7.36% |
2023 FY | 22.92 Million USD | -11.86% |
2022 FY | 26.01 Million USD | -6.34% |
2022 Q3 | 28.05 Million USD | -1.41% |
2022 Q2 | 28.45 Million USD | -0.23% |
2022 Q1 | 28.52 Million USD | 2.7% |
2022 Q4 | 26.01 Million USD | -7.28% |
2021 FY | 27.77 Million USD | 227.18% |
2021 Q4 | 27.77 Million USD | -3.62% |
2021 Q1 | 9.48 Million USD | 11.72% |
2021 Q2 | 6.93 Million USD | -26.85% |
2021 Q3 | 28.81 Million USD | 315.35% |
2020 FY | 8.48 Million USD | -45.75% |
2020 Q4 | 8.48 Million USD | 21.78% |
2020 Q3 | 6.97 Million USD | -24.17% |
2020 Q2 | 9.19 Million USD | 7.05% |
2020 Q1 | 8.58 Million USD | -45.12% |
2019 Q1 | 23.29 Million USD | 1.05% |
2019 Q4 | 15.64 Million USD | 20.29% |
2019 Q2 | 16.54 Million USD | -29.0% |
2019 FY | 15.64 Million USD | -32.13% |
2019 Q3 | 13 Million USD | -21.36% |
2018 Q3 | 15.22 Million USD | -13.95% |
2018 Q1 | 17.56 Million USD | -4.7% |
2018 FY | 23.05 Million USD | 25.09% |
2018 Q2 | 17.69 Million USD | 0.75% |
2018 Q4 | 23.05 Million USD | 51.4% |
2017 Q1 | 19.17 Million USD | -8.47% |
2017 Q3 | 16.13 Million USD | -16.9% |
2017 Q2 | 19.41 Million USD | 1.27% |
2017 Q4 | 18.42 Million USD | 14.21% |
2017 FY | 18.42 Million USD | -12.03% |
2016 Q3 | 18.89 Million USD | -13.12% |
2016 Q1 | 22.43 Million USD | -14.19% |
2016 Q2 | 21.75 Million USD | -3.06% |
2016 Q4 | 20.94 Million USD | 10.86% |
2016 FY | 20.94 Million USD | -19.88% |
2015 Q4 | 26.14 Million USD | 5.78% |
2015 Q1 | 27.38 Million USD | -9.14% |
2015 Q2 | 29.42 Million USD | 7.45% |
2015 Q3 | 24.71 Million USD | -15.99% |
2015 FY | 26.14 Million USD | -13.24% |
2014 Q2 | 31.07 Million USD | 7.96% |
2014 Q1 | 28.78 Million USD | -5.58% |
2014 FY | 30.13 Million USD | -1.14% |
2014 Q3 | 27.02 Million USD | -13.04% |
2014 Q4 | 30.13 Million USD | 11.53% |
2013 FY | 30.48 Million USD | -10.44% |
2013 Q4 | 30.48 Million USD | -22.95% |
2013 Q1 | 32.99 Million USD | -3.08% |
2013 Q3 | 39.57 Million USD | 12.52% |
2013 Q2 | 35.16 Million USD | 6.59% |
2012 FY | 34.04 Million USD | 98.58% |
2012 Q2 | 13.51 Million USD | -15.41% |
2012 Q1 | 15.97 Million USD | -6.83% |
2012 Q4 | 34.04 Million USD | -6.71% |
2012 Q3 | 36.48 Million USD | 170.07% |
2011 FY | 17.14 Million USD | 81.96% |
2011 Q4 | 17.14 Million USD | 128.65% |
2011 Q2 | 8.14 Million USD | 2.13% |
2011 Q1 | 7.97 Million USD | -15.36% |
2011 Q3 | 7.49 Million USD | -7.94% |
2010 Q3 | 8.79 Million USD | -5.31% |
2010 Q1 | 8.71 Million USD | -0.91% |
2010 FY | 9.42 Million USD | 7.14% |
2010 Q2 | 9.29 Million USD | 6.66% |
2010 Q4 | 9.42 Million USD | 7.06% |
2009 Q2 | 8.95 Million USD | 8.36% |
2009 Q1 | 8.26 Million USD | -14.22% |
2009 FY | 8.79 Million USD | -8.74% |
2009 Q3 | 8.54 Million USD | -4.54% |
2009 Q4 | 8.79 Million USD | 2.85% |
2008 Q2 | 6.79 Million USD | -3.28% |
2008 Q4 | 9.63 Million USD | 1.53% |
2008 FY | 9.63 Million USD | 21.87% |
2008 Q1 | 7.02 Million USD | -11.09% |
2008 Q3 | 9.48 Million USD | 39.57% |
2007 Q2 | 4.61 Million USD | 3.03% |
2007 Q3 | 5.19 Million USD | 12.46% |
2007 Q4 | 7.9 Million USD | 52.24% |
2007 FY | 7.9 Million USD | 18.77% |
2007 Q1 | 4.48 Million USD | -32.67% |
2006 Q4 | 6.65 Million USD | 19.34% |
2006 Q3 | 5.57 Million USD | -23.06% |
2006 Q2 | 7.24 Million USD | 3.43% |
2006 Q1 | 7 Million USD | -13.27% |
2006 FY | 6.65 Million USD | -17.63% |
2005 Q2 | 6.49 Million USD | 1.59% |
2005 Q1 | 6.39 Million USD | 1.75% |
2005 Q3 | 6.14 Million USD | -5.34% |
2005 FY | 8.08 Million USD | 28.67% |
2005 Q4 | 8.08 Million USD | 31.5% |
2004 FY | 6.28 Million USD | -38.49% |
2004 Q4 | 6.28 Million USD | 4.71% |
2004 Q3 | 5.99 Million USD | -14.99% |
2004 Q2 | 7.05 Million USD | -2.95% |
2004 Q1 | 7.27 Million USD | -28.79% |
2003 FY | 10.21 Million USD | -10.19% |
2003 Q4 | 10.21 Million USD | 10.89% |
2003 Q3 | 9.2 Million USD | -11.13% |
2003 Q2 | 10.36 Million USD | 1.32% |
2003 Q1 | 10.22 Million USD | -10.06% |
2002 Q1 | 10.05 Million USD | -5.16% |
2002 Q3 | 10.95 Million USD | 1.33% |
2002 FY | 11.37 Million USD | 7.24% |
2002 Q2 | 10.81 Million USD | 7.54% |
2002 Q4 | 11.37 Million USD | 3.76% |
2001 Q2 | 11.05 Million USD | 0.89% |
2001 FY | 10.6 Million USD | -9.4% |
2001 Q1 | 10.96 Million USD | -6.33% |
2001 Q3 | 10.71 Million USD | -3.13% |
2001 Q4 | 10.6 Million USD | -1.03% |
2000 FY | 11.7 Million USD | -3.28% |
2000 Q2 | 11.46 Million USD | -2.8% |
2000 Q4 | 11.7 Million USD | 6.69% |
2000 Q3 | 10.96 Million USD | -4.29% |
2000 Q1 | 11.79 Million USD | -2.55% |
1999 Q4 | 12.1 Million USD | 4.31% |
1999 FY | 12.1 Million USD | 3.42% |
1999 Q3 | 11.6 Million USD | 0.0% |
1999 Q1 | 11.4 Million USD | -2.56% |
1999 Q2 | 11.6 Million USD | 1.75% |
1998 FY | 11.7 Million USD | 116.67% |
1998 Q1 | 5 Million USD | -7.41% |
1998 Q4 | 11.7 Million USD | 11.43% |
1998 Q3 | 10.5 Million USD | -3.67% |
1998 Q2 | 10.9 Million USD | 118.0% |
1997 FY | 5.4 Million USD | 58.82% |
1997 Q2 | 3.7 Million USD | 23.33% |
1997 Q3 | 4.4 Million USD | 18.92% |
1997 Q4 | 5.4 Million USD | 22.73% |
1997 Q1 | 3 Million USD | -11.76% |
1996 Q2 | 3.2 Million USD | -25.58% |
1996 FY | 3.4 Million USD | 25.93% |
1996 Q4 | 3.4 Million USD | -10.53% |
1996 Q1 | 4.3 Million USD | 59.26% |
1996 Q3 | 3.8 Million USD | 18.75% |
1995 FY | 2.7 Million USD | 0.0% |
1995 Q4 | 2.7 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Augmedix, Inc. | 43.39 Million USD | 47.164% |
CareCloud, Inc. | 37.79 Million USD | 39.344% |
HealthEquity, Inc. | 1.2 Billion USD | 98.092% |
iCoreConnect Inc. | 11.24 Million USD | -103.926% |
Progyny, Inc. | 203.19 Million USD | 88.717% |
Renalytix Plc | 15.82 Million USD | -44.863% |
SOPHiA GENETICS SA | 54.71 Million USD | 58.098% |
Omnicell, Inc. | 1.03 Billion USD | 97.791% |
Ontrak, Inc. | 5.57 Million USD | -311.229% |
Minerva Surgical, Inc. | 51.71 Million USD | 55.672% |
Accolade, Inc. | 342.68 Million USD | 93.31% |
BrightSpring Health Services, Inc. Common Stock | 5.17 Billion USD | 99.557% |
CareCloud, Inc. | 37.79 Million USD | 39.344% |
Health Catalyst, Inc. | 334.89 Million USD | 93.154% |
HealthStream, Inc. | 159.19 Million USD | 85.598% |
Inovalon Holdings, Inc. | 1.26 Billion USD | 98.184% |
Nutex Health, Inc. | 319.13 Million USD | 92.816% |
OneMedNet Corporation | 13.32 Million USD | -72.083% |
Schrödinger, Inc. | 254.39 Million USD | 90.988% |
Simulations Plus, Inc. | 14.2 Million USD | -61.36% |
GE HealthCare Technologies Inc. | 25.14 Billion USD | 99.909% |
Sharecare, Inc. | 125.56 Million USD | 81.742% |
Aclarion, Inc. | 3.18 Million USD | -619.186% |
CareMax, Inc. | 561.85 Million USD | 95.92% |
Bullfrog AI Holdings, Inc. Common Stock | 184.35 Thousand USD | -12336.127% |
Forian Inc. | 33.19 Million USD | 30.938% |
Bullfrog AI Holdings, Inc. Warrants | 184.35 Thousand USD | -12336.127% |
HeartBeam, Inc. | 1.19 Million USD | -1820.101% |
GeneDx Holdings Corp. | 245.65 Million USD | 90.667% |
SCWorx Corp. | 2.42 Million USD | -845.493% |
Definitive Healthcare Corp. | 626.72 Million USD | 96.342% |
10x Genomics, Inc. | 224.1 Million USD | 89.77% |
Zhongchao Inc. | 3.37 Million USD | -578.591% |
MSP Recovery, Inc. | 1.74 Billion USD | 98.683% |
R1 RCM Inc. | 2.2 Billion USD | 98.962% |
Spok Holdings, Inc. | 63.91 Million USD | 64.129% |
Privia Health Group, Inc. | 392.51 Million USD | 94.159% |
EUDA Health Holdings Limited | 8.79 Million USD | -160.747% |
TruBridge, Inc. | 247.8 Million USD | 90.748% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 5.17 Billion USD | 99.557% |
Sharecare, Inc. | 125.56 Million USD | 81.742% |
GoodRx Holdings, Inc. | 826.84 Million USD | 97.227% |
Premier, Inc. | 1.46 Billion USD | 98.437% |
Certara, Inc. | 516.29 Million USD | 95.56% |
GeneDx Holdings Corp. | 245.65 Million USD | 90.667% |
Ontrak, Inc. | 5.57 Million USD | -311.229% |
SHL Telemedicine Ltd. | 36.58 Million USD | 37.34% |
CareCloud, Inc. | 37.79 Million USD | 39.344% |
EUDA Health Holdings Limited | 8.79 Million USD | -160.747% |
HeartBeam, Inc. | 1.19 Million USD | -1820.101% |
Mangoceuticals, Inc. | 276.03 Thousand USD | -8205.348% |
CareMax, Inc. | 561.85 Million USD | 95.92% |
Healthcare Triangle, Inc. | 9.51 Million USD | -141.047% |
National Research Corporation | 73.48 Million USD | 68.801% |
Aclarion, Inc. | 3.18 Million USD | -619.186% |
OptimizeRx Corporation | 56.82 Million USD | 59.652% |